Clinical Trial Update: Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating ropivacaine perfusion after mastectomy versus placebo has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED